Showing results (141-150 of 212) with videos related to
Sort By:
Pageof 22
Bioinformatics (Oxford, England)|February 1, 2012
Inhibition of HIV-1 protease: the rigidity perspectiveJ W Heal, J E Jimenez-Roldan, S A Wells, et al.Genes, Chromosomes & Cancer|November 1, 1995
Frequent mutations of CDKN2 in primary pancreatic adenocarcinomasD Bartsch, D W Shevlin, W S Tung, et al.Human Genetics|April 1, 1993
Development of a sequence-tagged site for the centromere of chromosome 10: its use in cytogenetic and physical mappingJ R Howe, T C Lairmore, R Veile, et al.Annals of Surgery|May 1, 1980
The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastasesD E Haagensen, W F Barry, T A McCook, et al.Journal of the National Cancer Institute|January 1, 1983
Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinomaW G Dilley, G S Leight, J S Silva, et al.Journal of the National Cancer Institute|February 1, 1979
Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component proteinD E Haagensen, G Mazoujian, W G Dilley, et al.Annals of Internal Medicine|January 1, 1982
Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinomaR J Santen, T J Worgul, A Lipton, et al.Henry Ford Hospital Medical Journal|January 11, 1992
Oncogene and growth factor expression in MEN 2 and related tumorsJ F Moley, G K Wallin, M B Brother, et al.Annals of Surgery|December 1, 1978
Alterations in plasma norepinephrine concentration during surgical resection of pheochromocytomaJ M Feldman, J A Blalock, L Fagraeus, et al.Molecular Carcinogenesis|January 1, 1996
Infrequent CDKN2 mutation in human differentiated thyroid cancersW S Tung, D W Shevlin, D Bartsch, et al.Pageof 22